Clinical Trials in New York

Showing 17381-17400 of 22,668 trials

A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia

NCT00048035

This study will determine the appropriate dose and frequency of administration of iv Mircera maintenance therapy in hemodialysis patients with chronic renal anemia who were previously receiving iv epoetin. The anticipated time on study treatment is 3-12 months and the target sample size is \<100 individuals.

Anemia

Hoffmann-La Roche91 participantsStarted Mar 2002

Birmingham, Alabama, United States • Los Angeles, California, United States • Maywood, Illinois, United States +11 more locations

COMPLETEDPhase 3< 1 mile

Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris

NCT02865005

Multi-center, double-blind, randomized, placebo-controlled trial of Dapsone 5.0% Gel in the treatment of acne vulgaris.

Acne Vulgaris

Seegpharm S.A.2,361 participantsStarted Feb 2016

Encino, California, United States • Fullerton, California, United States • La Mesa, California, United States +33 more locations

A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia

Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris

Find Trials by Condition in New York

Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs

Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV

Open Label Pilot Study of Apremilast in Treatment of Rosacea

Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)

Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort

Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment

GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers

The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease

A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease

Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB

Assessment of the Clinical Performance of the ARROW-FLU System

SinuSys Patency of Frontal Recess and Sphenoid Sinus Ostia Study

A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast Cancer

Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127)

A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)